Viral respiratory diseases (including influenza and COVID-19) in Scotland surveillance report

About this release

This weekly release by Public Health Scotland presents epidemiological information on respiratory infection activity, including COVID-19, across Scotland. Due to the dynamic nature of all datasets included in this report, figures contained within each update may be subject to change in future releases. Any revised figures will then be reflected within the latest update.

Main points

Overall assessment 5 February to 11 February (ISO week 6): 

• Measures of respiratory symptoms in the community via calls to NHS24 and attendances at GP consultations (GP ILI) were at Baseline activity level.
• In the CARI community surveillance system, swab positivity for influenza A decreased to 15.9% from 18.8% in the previous week, while increasing for seasonal coronavirus (non-COVID-19) to 15.5% (from 11.4%), and for rhinovirus to 14.8% (from 12.8%). Swab positivity remained elevated but stable for Mycoplasma pneumoniae at 8.9%, and human metapneumovirus at 9.0%. All other pathogens remained stable at <5% swab positivity.
• Virology data showed influenza decreased to Moderate activity level in week 6. All age groups have decreased to or remained at Moderate activity level. RSV remained at Baseline activity level while Mycoplasma pneumoniae decreased to Moderate activity level.
• Emergency hospital admissions because of influenza continued to decrease from 322 to 311, as did RSV, from 43 to 26 and COVID-19 from 207 to 143. ICU/HDU admissions decreased for influenza. There were no ICU/ HDU admissions for RSV and fewer than 5 for COVID-19.
• All-cause excess mortality for week 3 (week ending 21 January 2024, the latest week not impacted by reporting delays) increased to Low activity level overall and for the 15-64 age group. All other age groups remained at Baseline activity level.
• In winter 2023/24, Scotland administered 1,649,855 influenza (Adult 18+), 538,520 influenza (Children 6 months to 17 years) and 1,390,652 COVID-19 vaccines since September 4, 2023. Among adults 65+, 80.0% received influenza, and 79.2% received COVID-19 vaccines by week 6. Uptake is lower for both influenza and COVID-19 vaccines compared to winter 2022/23.
• Vaccine effectiveness (VE) against influenza infection amongst hospital admissions ranged from 54% to 64% for all ages. VE against infection with influenza (all types) among people of all ages in the community was 53% (44 to 60%).

Background

Tracking infectious respiratory diseases, including COVID-19 and influenza, is essential, especially in the winter when the disease burden can be highest. In Scotland, respiratory infection and associated morbidity are monitored using enhanced surveillance. This approach combines data from microbiological sampling and laboratory test results from community and hospital settings with data from syndromic surveillance of NHS 24 calls, primary care consultations for respiratory symptoms, hospital (including intensive care) admissions and other settings.

The intelligence generated from surveillance of laboratory, syndromic and community settings provide a comprehensive picture of current respiratory illness in Scotland. The data presented in this report provide a comprehensive and timely epidemiological picture that is essential for understanding transmission of infection and supporting patient care and NHS service planning and policy.

Seasonality patterns / seasonal variations

Respiratory illnesses are associated with seasonal increase in the autumn and winter. Seasonality patterns for both influenza viruses and non-influenza respiratory pathogens have been established through many years of surveillance data. Most influenza and non-influenza pathogens circulate in the autumn and winter in Scotland, although some are known to circulate in the spring and summer. Notably, COVID-19 transmission has been occurring in waves throughout the year as observed from surveillance data since the start of the pandemic in 2020.

Further information

The next release will be on 22 February 2024.

Find out more

Previous Publications

Versions of the Weekly national respiratory report publication released before 30 November 2022 may be found on the Public Health Scotland website.

Versions of the COVID-19 weekly statistical report publication released before 30 November 2022 may be found on the Public Health Scotland website.

Open data

Open data from this publication is available from the following weblinks:

• Viral respiratory diseases Open Data platform
• Flu and COVID vaccination uptake Open Data platform

Further data

• The COVID-19 Vaccine Wastage datafile was updated on 14 September 2023 to include the most recent information.
• The COVID-19 in Adult Care Homes in Scotland datafile was updated on 27 July 2023 to include more recent information.
• 28 September 2022 COVID-19 statistical report publication contains information on COVID-19 infection and vaccination in pregnancy in Scotland.
• 2 March 2022 COVID-19 statistical report publication contains information on Highest Risk (shielding patients list)
• 7 November 2023 Community Acute Respiratory Infection (CARI) surveillance in primary care contains information on flu Vaccine effectiveness in community settings.
• 25 May 2023 Interim 2022/23 influenza vaccine effectiveness: six European studies, October 2022 to January 2023, contains information on flu Vaccine effectiveness in hospital settings.
• 13 January 2024 Estimated number of lives directly saved by COVID-19 vaccination programs in the WHO European Region, December 2020 to March 2023, contains information on lives saved due to COVID-19 vaccination
• The COVID-19 Vaccine Wastage datafile was updated on 18 April 2024 to include the most recent information.